Clinical Trial Update: Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating prophylactic intravesical chemotherapy to prevent bladder tumor recurrence after nephroureterectomy for primary upper tract ur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Upper Tract Urothelial Carcinoma

Snippet

Sponsor: Xuesong Li | Conditions: Upper Tract Urothelial Carcinoma, Bladder Recurrence | Phase 2 | Status: UNKNOWN